Meta-Analysis
Copyright ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Meta-Anal. Apr 26, 2017; 5(2): 63-70
Published online Apr 26, 2017. doi: 10.13105/wjma.v5.i2.63
Mucin expression and the pancreas: A systematic review and meta-analysis
Yaron Niv
Yaron Niv, Department of Gastroenterology, Rabin Medical Center, Tel Aviv University, Petach Tikva 4910000, Israel
Author contributions: Niv Y solely contributed to this paper.
Conflict-of-interest statement: None.
Data sharing statement: None.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Yaron Niv, MD, FACG, AGAF, Professor, Department of Gastroenterology, Rabin Medical Center, Tel Aviv University, 49 Jabotinski Street, Petach Tikva 4910000, Israel. nivyaron80@gmail.com
Telephone: +972-3-9377328 Fax: +972-3-9377341
Received: October 3, 2016
Peer-review started: October 8, 2016
First decision: November 29, 2016
Revised: February 17, 2017
Accepted: March 12, 2017
Article in press: March 13, 2017
Published online: April 26, 2017
Core Tip

Core tip: There is a higher mucin expression in intraductal papillary mucinous neoplasms (IPMN) and ductal pancreatic cancer. Mucin expression may be a bad prognostic factor. MUC2, MUC4, MUC5AC and probably MUC1, are expressed in IPMN advanced to ductal adenocarcinoma. These mucins are also bad prognostic factors for ductal adenocarcinoma.